Latest Regulatory News

Spacetalk launches its subscription-based Freedom Platform, aiming to transform family safety tech and hit $20-25 million in annual recurring revenue by 2026. The new app connects multiple generations, expanding beyond smartwatches into a broader digital ecosystem.

Bryah Resources has secured approvals and land access agreements to begin drilling at its Golden Pike Project in Canada, targeting high-grade gold and antimony deposits with programs set to complete by year-end.

Diablo Resources has appointed Matthew Blumberg as a Non-Executive Director and brought on Ellis Martin as its U.S. Media and Investor Communications Advisor, signaling a strategic push into North American markets.

Algorae Pharmaceuticals has announced a non-renounceable Loyalty Options Offer to eligible shareholders, aiming to raise up to $337,678 before costs, with potential additional capital of $4.7 million if all options are exercised. The capital raise supports the company’s pharmaceutical and AI research and development ambitions.

Race Oncology has announced pivotal new clinical trials for its lead asset RC220, aiming to accelerate regulatory approval in Acute Myeloid Leukemia and tackle resistance in Non-Small Cell Lung Cancer.

Kingsgate Consolidated Limited is nearing a resolution in its long-standing TAFTA dispute with the Kingdom of Thailand, signaling potential progress in a complex international trade matter.

Capricorn Metals Ltd has had its CMMO securities class suspended from ASX trading pending regulatory compliance, raising questions about the company’s next steps.

TPG Telecom has launched a $688 million Reinvestment Plan offering new shares to eligible shareholders, aiming to offset the impact of a recent cash distribution and enhance market liquidity. The plan includes institutional and retail components priced at a discount, forming a key part of the company’s broader capital management strategy.

CVC Limited has successfully completed an upsized $75 million capital raise through its Notes 3 offer, setting a 4.50% annual margin. The funds will support general corporate needs and potential debt consolidation.

Metals X Limited has updated its Renison Tin Operations Ore Reserve, reporting a 7.5 million tonne reserve with 102,720 tonnes of contained tin, reflecting an 8.5% decline from last year but affirming a near-decade mine life.

Tivan Limited has locked in a substantial $61.3 million equity investment from ETFS Capital, advancing the Speewah Fluorite Project in Western Australia and reinforcing its strategic partnerships with major Japanese stakeholders.

Radiopharm Theranostics has reached the halfway mark in enrolling patients for its Phase 2b trial of RAD101, a novel imaging agent targeting brain metastases. Early data suggest RAD101 may outperform MRI in distinguishing tumor recurrence from radiation damage.